We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+16.35%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$253M
AUM Growth
+$68.5M
Cap. Flow
+$41.6M
Cap. Flow %
16.45%
Top 10 Hldgs %
75.72%
Holding
68
New
6
Increased
21
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$26.1M
2
GSLC icon
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
+$9.33M
3
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$5.08M
4
IBRX icon
ImmunityBio
IBRX
+$1.37M
5
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$613K

Top Sells

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$1.3M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$442K
3
RMD icon
ResMed
RMD
+$254K
4
IWB icon
iShares Russell 1000 ETF
IWB
+$253K
5
AAL icon
American Airlines Group
AAL
+$242K

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.78%
2 Healthcare 28.43%
3 Real Estate 1.02%
4 Financials 0.27%
5 Materials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWC icon
51
iShares MSCI Canada ETF
EWC
$6.85B
$277K 0.11%
12,892
+3
+0% +$70
DLN icon
52
WisdomTree US LargeCap Dividend Fund
DLN
$6.35B
$267K 0.11%
7,520
– –
AMLP icon
53
Alerian MLP ETF
AMLP
$13.4B
$251K 0.1%
+4,170
New +$261K
CELG
54
DELISTED
Celgene Corp
CELG
$251K 0.1%
2,100
– –
RGLS
55
DELISTED
Regulus Therapeutics
RGLS
$250K 0.1%
238
-31
-12% -$31.1K
VGT icon
56
Vanguard Information Technology ETF
VGT
$147B
$242K 0.1%
17,912
– –
DBEF icon
57
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.38B
$239K 0.09%
8,791
-8,538
-49% -$236K
EPP icon
58
iShares MSCI Pacific ex Japan ETF
EPP
$2.32B
$223K 0.09%
5,808
-3,694
-39% -$144K
IVV icon
59
iShares Core S&P 500 ETF
IVV
$898B
$209K 0.08%
+1,020
New +$211K
ASRT
60
DELISTED
Assertio
ASRT
$181K 0.07%
167
– –
BAC icon
61
Bank of America
BAC
$436B
$171K 0.07%
+10,165
New +$172K
SEEL
62
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
– –
0
– –
BIOC
63
DELISTED
Biocept, Inc.
BIOC
$52K 0.02%
1
– –
APTO
64
DELISTED
Aptose Biosciences, Inc.
APTO
$30K 0.01%
+27
New +$47.8K
AAL icon
65
American Airlines Group
AAL
$9.03B
– –
-6,238
Closed -$242K
HALO icon
66
Halozyme
HALO
$12B
– –
-12,230
Closed -$164K
IWB icon
67
iShares Russell 1000 ETF
IWB
$49.1B
– –
-2,368
Closed -$253K
MINT icon
68
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.4B
– –
-12,950
Closed -$1.3M
1 2
3

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Callan Capital held 68 positions worth $253M, up 37% from $184M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Callan Capital deployed $41.6M of net new capital in Q4 2015, opening 6 new positions and adding to 21 existing holdings. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 224,339 shares worth $9.31M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, down from 71% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Schwab International Equity ETF, an estimated $442K trimmed.

  • Callan Capital's largest Q4 2015 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 224,339 shares worth $9.31M.
  • Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q4 2015, an estimated $26.1M increase.
  • Callan Capital's biggest Q4 2015 reduction was Schwab International Equity ETF, cutting an estimated $442K.
  • Callan Capital fully exited PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2015, selling an estimated $1.3M.
  • Callan Capital's ten largest holdings make up 76% of its $253M portfolio in Q4 2015.
  • Callan Capital opened 6 new positions and closed 4 in Q4 2015.
  • Callan Capital's portfolio value rose 37% quarter-over-quarter to $253M.

Based on Callan Capital's 13F filing for Q4 2015, filed 12 Feb 2016.